Figure 11: The Median Medicare Part D Plan: Total Cost by Drug
From, “Why Drug Pricing Reform is Complicated: A Primer and Policy Guide to Pharmaceutical Prices in the US,” by Craig Garthwaite and Amanda Starc.
Sign up to stay connected with the Aspen Economic Strategy Group and be among the first to know about our upcoming publications and events.
Sign Up